The FDA's Revolving Door Raises Ethical Questions September 28, 2016 Genevieve Pham-Kanter, PhD, assistant professor of Health Management and Policy, commented on an outside study which offers concrete evidence of a revolving door between the Food and Drug Administration and drug companies. Pham-Kanter's research, showing that financial ties to drug companies do sway independent FDA advisers, was cited by Modern Healthcare and STAT. View Story
icon above to turn off Compatibility Mode, which is only for viewing older websites.